Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02278783
Title Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Utah

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer



Age Groups: adult
Covered Countries USA

No variant requirements are available.